Floatz logo

Therapeutic Asset Ratings

3,272 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Dexasone
Adrenal Cortex Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Dexasone
Adrenal Gland Cancer
National Cancer Institute (NCI)P2CCC (53)
Dexasone
Adrenal Gland Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Dexasone
Adrenal Cortex Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Dexasone
Bile Duct Cancer
National Cancer Institute (NCI)P2CCC (53)
Dexasone
Bile Duct Neoplasm
National Cancer Institute (NCI)P2CCC (53)
Dexasone
Intrahepatic Bile Duct Cancer
National Cancer Institute (NCI)P2CCC (53)
Dinaciclib
Acral Lentiginous Melanoma
National Cancer Institute (NCI)P2CCC (53)
Dinaciclib
Nodular Malignant Melanoma
National Cancer Institute (NCI)P2CCC (53)
Dinaciclib
Lentigo Maligna Melanoma
National Cancer Institute (NCI)P2CCC (53)
Dinaciclib
Mucosal Melanoma
National Cancer Institute (NCI)P2CCC (53)
Dinaciclib
Cutaneous Melanoma
National Cancer Institute (NCI)P2CCC (53)
Docetaxel
Minimally Invasive Lung Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Endometrium Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Endometrial Mixed Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Endometrial Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Endometrial Undifferentiated Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Endometrioid Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Fallopian Tube Mucinous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Ovarian Seromucinous Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Fallopian Tube Clear Cell Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Fallopian Tube Endometrioid Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Fallopian Tube Serous Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Fallopian Tube Transitional Cell Carcinoma
National Cancer Institute (NCI)P2CCC (53)
Durvalumab
Ovarian Clear Cell Adenocarcinoma
National Cancer Institute (NCI)P2CCC (53)
Showing 1276 to 1300 of 3,272 assets
PreviousPage 52 of 131Next